PHS
DOCU

PFM Health Sciences’s DocuSign DOCU Stock Holding History

PFM Health Sciences’s Portfolio DOCU Stock Details DOCU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-19,199
Closed -$769K – 102
2018
Q4 		$769K Hold
19,199
– – 0.02% 90
2018
Q3 		$1.01M Hold
19,199
– – 0.01% 117
2018
Q2 		$1.02M Buy
+19,199
New +$969K 0.02% 113

Other funds holding DOCU

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
BCVI
Bain Capital Venture Investors Boston, Massachusetts $133M AUM 50.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PFM Health Sciences's DOCU Position: Q1 2019 in Review

PFM Health Sciences sold out of DocuSign (DOCU) in Q1 2019, closing a stake of 19,199 shares — an estimated $769K sold.

PFM Health Sciences first reported a position in DOCU in Q2 2018 and held it in 3 quarters. The position peaked at $1.02M in Q2 2018. 348 funds tracked by Wall St. Rank hold DOCU as of Q1 2019.

  • PFM Health Sciences reported no remaining DocuSign position as of Q1 2019 after selling out during the quarter.
  • PFM Health Sciences sold 19,199 DocuSign shares in Q1 2019, an estimated $769K.
  • PFM Health Sciences first reported a position in DocuSign in Q2 2018 and held it in 3 quarters.
  • PFM Health Sciences's DocuSign position peaked at $1.02M in Q2 2018.
  • 348 funds tracked by Wall St. Rank held DocuSign as of Q1 2019.

Based on PFM Health Sciences's 13F filing for Q1 2019, filed 15 May 2019.